Skip to main content

. 1987 Dec 5;295(6611):1446–1447. doi: 10.1136/bmj.295.6611.1446

Cervical adenocarcinoma and oral contraceptives.

C Chilvers ¹, D Mant ¹, M C Pike ¹

PMCID: PMC1248605 PMID: 3121057

1446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract. 1984 Sep;179(1):38–50. doi: 10.1016/S0344-0338(84)80059-X. [DOI] [PubMed] [Google Scholar]
Mingeot R., Fievez C. Endocervical changes with the use of synthetic steroids. Obstet Gynecol. 1974 Jul;44(1):53–59. [PubMed] [Google Scholar]
Peters R. K., Chao A., Mack T. M., Thomas D., Bernstein L., Henderson B. E. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst. 1986 Mar;76(3):423–428. [PubMed] [Google Scholar]
Schwartz S. M., Weiss N. S. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol. 1986 Dec;124(6):1045–1047. doi: 10.1093/oxfordjournals.aje.a114474. [DOI] [PubMed] [Google Scholar]
Silcocks P. B., Thornton-Jones H., Murphy M. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer. 1987 Mar;55(3):321–325. doi: 10.1038/bjc.1987.63. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES